Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab
Aug 08, 2017 11:30 am UTC| Business
- Dermira plans to develop and commercialize lebrikizumab, a monoclonal antibody targeting IL-13, for moderate-to-severe atopic dermatitis - Initiation of a Phase 2b clinical study is expected in the first quarter of...
Neuralstem Reports Second Quarter 2017 Fiscal Results and Provides Clinical and Business Update
Aug 08, 2017 11:30 am UTC| Business
GERMANTOWN, Md., Aug. 08, 2017 -- Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial...
Aug 08, 2017 11:30 am UTC| Business
Study Confirms Intranasal Abuse of Hydrocodone/Acetaminophen by Adolescents Adults may be a Significant Public Health Issue CORALVILLE, Iowa, Aug. 08, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty...
Aug 08, 2017 11:30 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Aug. 08, 2017 -- Altisource Residential Corporation (“RESI” or the “Company”) (NYSE:RESI) today announced financial and operating results for the second quarter of 2017. Second...
Aug 08, 2017 11:30 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Aug. 08, 2017 -- Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE MKT:AAMC) today announced financial and operating results for the second quarter of 2017. ...
KalVista Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference
Aug 08, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, Aug. 08, 2017 -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
Aug 08, 2017 11:30 am UTC| Business
TULSA, Okla., Aug. 08, 2017 -- Matrix Service Company (Nasdaq:MTRX) announced today that its subsidiary, Matrix PDM Engineering, has begun advance procurement of long-lead items needed for the construction of the...